Abstract:Since the report of "DNA untwisting" activity in 1972, ~50 years of research has revealed seven topoisomerases in humans (TOP1, TOP1mt, TOP2α, TOP2β, TOP3α, TOP3β and Spo11). These conserved regulators of DNA topology catalyze controlled breakage to the DNA backbone to relieve the torsional stress that accumulates during essential DNA transactions including DNA replication, transcription, and DNA repair. Each topoisomerase-catalyzed reaction involves the formation of a topoisomerase cleavage complex (TOPcc), a covalent protein-DNA reaction intermediate formed between the DNA phosphodiester backbone and a topoisomerase catalytic tyrosine residue. A variety of perturbations to topoisomerase reaction cycles can trigger failure of the enzyme to re-ligate the broken DNA strand(s), thereby generating topoisomerase DNA-protein crosslinks (TOP-DPC). TOP-DPCs pose unique threats to genomic integrity. These complex lesions are comprised of structurally diverse protein components covalently linked to genomic DNA, which are bulky DNA adducts that can directly impact progression of the transcription and DNA replication apparatus. A variety of genome maintenance pathways have evolved to recognize and resolve TOP-DPCs. Eukaryotic cells harbor tyrosyl DNA phosphodiesterases (TDPs) that directly reverse 3′-phosphotyrosyl (TDP1) and 5′-phoshotyrosyl (TDP2) protein-DNA linkages. The broad specificity Mre11-Rad50-Nbs1 and APE2 nucleases are also critical for mitigating topoisomerase-generated DNA damage. These DNA-protein crosslink metabolizing enzymes are further enabled by proteolytic degradation, with the proteasome, Spartan, GCNA, Ddi2, and FAM111A proteases implicated thus far. Strategies to target, unfold, and degrade the protein component of TOP-DPCs have evolved as well. Here we survey mechanisms for addressing Topoisomerase 1 (TOP1) and Topoisomerase 2 (TOP2) DPCs, highlighting systems for which molecular structure information has illuminated function of these critical DNA damage response pathways.

Mapping catalytically engaged TOP2B in neurons reveals the principles of topoisomerase action within the genome

Inhibition of topoisomerase 2 catalytic activity impacts the integrity of heterochromatin and repetitive DNA and leads to interlinks between clustered repeats

Topoisomerase IIβ targets DNA crossovers formed between distant homologous sites to modulate chromatin structure and gene expression

RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription

Topoisomerase IIβ targets DNA crossovers formed between distant homologous sites to induce chromatin opening

Topoisomerase IIA in adult NSCs regulates SVZ neurogenesis by transcriptional activation of Usp37

Type II topoisomerases shape multi-scale 3D chromatin folding in regions of positive supercoils

Topoisomerase 1 Regulates Gene Expression in Neurons Through Cleavage Complex-Dependent and -Independent Mechanisms.

Genome-wide Mapping of Topoisomerase Binding Sites Suggests Topoisomerase 3α(TOP3A) as a Reader of Transcription-Replication Conflicts (TRC)

Topoisomerase IIb binding underlies frequently mutated elements in cancer genomes

Bioinformatic Analysis of Topoisomerase IIα Reveals Interdomain Interdependencies and Critical C-Terminal Domain Residues

RNA interacts with topoisomerase I to adjust DNA topology

Consistent rationalization of type-2 topoisomerases' unknotting, decatenating, supercoil-relaxing actions and their scaling relation.

Topoisomerase II Regulates the Maintenance of DNA Methylation

Human topoisomerases and their roles in genome stability and organization

Topological regulation of the estrogen transcriptional response by ZATT-mediated inhibition of TOP2B activity

Post-translational modifications in DNA topoisomerase 2α highlight the role of a eukaryote-specific residue in the ATPase domain

From the TOP: Formation, Recognition and Resolution of Topoisomerase DNA Protein Crosslinks

Physiological regulation of eukaryotic topoisomerase II

Highly sensitive mapping of in vitro type II topoisomerase DNA cleavage sites with SHAN-seq

Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.